MiR-497∼195 cluster regulates angiogenesis during coupling with osteogenesis by maintaining endothelial Notch and HIF-1α activity.

Yang, Mi; Li, Chang-Jun; Sun, Xi; Guo, Qi; Xiao, Ye; Su, Tian; Tu, Man-Li; Peng, Hui et al. · Nat Commun · 2017

basic_science · Level V

Where this comes from

Abstract

A specific bone vessel subtype, strongly positive for CD31 and endomucin (CD31<sup>hi</sup>Emcn<sup>hi</sup>), is identified as coupling angiogenesis and osteogenesis. The abundance of type CD31<sup>hi</sup>Emcn<sup>hi</sup> vessels decrease during ageing. Here we show that expression of the miR-497∼195 cluster is high in CD31<sup>hi</sup>Emcn<sup>hi</sup> endothelium but gradually decreases during ageing. Mice with depletion of miR-497∼195 in endothelial cells show fewer CD31<sup>hi</sup>Emcn<sup>hi</sup> vessels and lower bone mass. Conversely, transgenic overexpression of miR-497∼195 in murine endothelium alleviates age-related reduction of type CD31<sup>hi</sup>Emcn<sup>hi</sup> vessels and bone loss. miR-497∼195 cluster maintains the endothelial Notch activity and HIF-1α stability via targeting F-box and WD-40 domain protein (Fbxw7) and Prolyl 4-hydroxylase possessing a transmembrane domain (P4HTM) respectively. Notably, endothelialium-specific activation of miR-195 by intravenous injection of aptamer-agomiR-195 stimulates CD31<sup>hi</sup>Emcn<sup>hi</sup> vessel and bone formation in aged mice. Together, our study indicates that miR-497∼195 regulates angiogenesis coupled with osteogenesis and may represent a potential therapeutic target for age-related osteoporosis.

Medical subject headings